ArchiveCompared with traditional topical formulations, foam agents have many advantages, including easy application, less residue, high penetration, which are suitable for local administration to the skin or mucosa. Therefore, this dosage form has good patient compliance. Establishment of simple and reproducible evaluation method is particularly important for the development of foam agents. In addition, the researches on non-propellant, nanocarrier-based and bionic foam agents further expand the advantages of foam agents, and the application of new manufacturing technique accelerates the industrialization of foam agents. In this paper, the performance evaluations for the expansion, stability, density, rheology and permeability of foam agents, the recent research progress and manufacturing technique of foam agents are reviewed to provide some references for the development of green and efficient foam agents.
Vagina has the advantages of rich blood supply, large surface area and avoidance of liver first-pass effect, which is beneficial for the drug to exert its pharmacological effect. Among vaginal drug delivery systems, semi-solid formulations have a certain fluidity and a larger spreading area in the vagina compared with solid formulations, which increases the absorption of drugs by the vaginal mucosa. The temperature-responsive gel for vaginal use can respond to the change of temperature and transform to a semi-solid from a liquid, so it is easy to spread and resist the clearance effect of vaginal fluid. This paper reviews the quality characterization and in vitro evaluation methods of semi-solid preparations for vaginal use through literature search, hoping to provide some references for the further development of semi-solid preparations.
Bioinspired wet adhesives derived from natural sources have been widely studied in recent years because of the functions of accelerating wound healing, hemostasis, antibacterial, and drug sustained-release. In order to expound the application prospects of bioinspired wet adhesives in the field of biomedicines, this paper briefly summarizes the researches on bionic design, adhesion mechanism, characterization methods, safety strategies and clinical transformation of bioinspired wet adhesives. Bioinspired wet adhesives exhibit good adhesion ability in humid environments, so that they have potential application value in wound healing, bone adhesion, rapid hemostasis, and sustained-drug release. At present, the related researches mainly focuses on adhesion mechanism and functional transformation, and future research should consider the improvement of quality control to make up for the shortcomings of traditional clinical technologies.
Ionic liquids is a low-temperature subclass of molten salts formed by organic cations and organic or inorganic anions, and its melting point is generally less than 100 ℃. Due to the designability of its anion and cation structures and the emergence of biocompatible anions and cations, toxicity of ionic liquids has been reduced, and related researches on drug delivery based on ionic liquids are increased. This review briefly introduces the development and design principles of ionic liquids, and summarizes the roles of ionic liquids in transdermal drug delivery systems, such as increasing the solubility of poorly soluble drugs, changing the permeability of biofilms, acting as drug delivery carriers and forming active pharmaceutical ingredient-ionic liquids(API-ILs). Finally, the safety and clinical application of ionic liquids are summarized, and the future development is prospected.
Pickering emulsion is a kind of emulsion stabilized only by solid particles locating at oil-water interface. Because of their easily modified silanol group and porous structure, silicon dioxide particles are commonly used as the stabilizer of Pickering emulsion. This paper briefly introduces the stabilization mechanism and preparation methods of Pickering emulsion, then focuses on the surface functionalization methods of silicon dioxide particles and the effects of surface properties of silica dioxide particles, such as surface wettability, particle concentration, particle shape, particle size and particle density, on the stability and release characteristics of Pickering emulsion. Finally, the application of Pickering emulsion stabilized by silica dioxide particles to transdermal drug delivery systems is summarized.
Raman spectroscopy and imaging technology were applied to investigate percutaneous penetration profiles of drugs in this paper. Raman spectra of the ex vivo skin samples were collected by mapping technique. Then, a semiquantitative analysis model of concentration and signal intensity of an analyte had been established using multiple linear regression. On this basis, the contribution coefficients of concentration were presented in the form of heat maps to achieve the visual analysis of permeability distribution of the analyte in the skin. Percutaneous permeation analysis of salicylic acid in pig skins was conducted using Raman spectroscopy and imaging technology. The concentration contribution coefficients of salicylic acid were 0.231% and 0.275% in the stratum corneum, and 3.1×10–4 and 2.4×10–4 in the active epidermal layer in the parallel experiments. Compared with the results determined by HPLC method, it was found that the change trend of drug concentration by the two methods was consistent, indicating that the concentration contribution coefficient obtained by Raman spectroscopy could be used for semiquantitative analysis, which provided a new technical means for studying the percutaneous absorption characteristics of the analyte and formulation optimization. In addition, the permeation distribution of hyaluronic acid with different relative molecular weights in pig skin was also investigated by this method, and the visual analysis of distribution of macromolecular drugs in skin was also realized.
Posterior segment diseases are the leading causes of visual impairment and blindness, and their treatments are mainly based on invasive approaches with many complications, serious adverse reactions and poor patient compliance. Non-invasive ocular drug delivery systems should be developed to overcome the ocular absorption barriers, increase drug permeability into posterior segment, so as to improve the drug bioavailability in posterior segment. This paper overviews the ocular barriers and novel non-invasive strategies(including the use of penetration enhancers, nanotechnology and iontophoresis) of drug delivery to the posterior eye segment. Moreover, the challenges of translational medicine and candidate drugs under clinical trial are summarized. Finally, the prospects of non-invasive posterior segment delivery are put forward.
There are various dynamic and static anatomic barriers in human eyes. Traditional ophthalmic preparations have deficiencies, such as low bioavailability, frequent administration and potential side effects. Therefore, safe, effective and convenient treatment methods are urgently needed in clinic. Drug-device combination products have unique advantages in this respect. In this review, the design principles, usage methods, clinical advantages and clinical applications of new drug-device combination products are introduced. Finally, the development of ophthalmic drug-device combination is prospected.
Pancreatic cancer is one of the solid tumors with the worst prognosis. The overall survival rate after surgical resection of pancreatic cancer is quite low. Gemcitabine monotherapy and its combination therapy are the preferred treatment for pancreatic cancer. But it is easy for gemcitabine to generate drug resistance in vivo, which seriously affects the prognosis. In order to solve the drug resistance problem of gemcitabine, researchers have conducted many explorations and studies on new delivery systems such as liposomes, nanoparticles, and micelles. In this paper, the mechanism of gemcitabine resistance is introduced, and the application of gemcitabine nano-delivery systems in treating pancreatic cancer is reviewed to provide a reference for the gemcitabine delivery system development.
As a key in vitro quality evaluation index, the adsorption and desorption rates are essential for reducing the risk of clinical tests of aluminum adjuvant-containing vaccines. With the continuous upgrading of the evaluation methods and deepening of process research of aluminum adjuvant-containing vaccines, higher demands for reference materials that can be used for systematic and in-depth analyses of related products have been put forward. Based on the actual development experience of the preparation project, this paper mainly analyzes the characteristics of adjuvant and antigen, and preparation technology. Also, it gives some suggestions for improvement in the evaluation method design. At the same time, it systematically describes the factors affecting the adsorption and desorption rates of aluminum adjuvant-containing vaccines, such as excipients, aluminum adjuvant, preparation process, and determination methods, to provide modest references for the research and development activities of pharmaceutical products.
Halogenated nitrophenol intermediates(containing fluorine, chlorine or bromine, etc.) generally show strong pharmacological and toxicological activities. They are previously applied in the synthesis of dyes and pesticides and now frequently use as the high valued pharmaceuticals. This article reviews the application and synthetic process of halogenated nitrophenol intermediates in recent years. The crucial processes are mainly divided into three ones, namely hydrolysis, halogenation and nitration. Among them, the hydrolysis process mostly utilizes strong alkalis and high temperature that might be relatively harsh conditions. The limitation of halogenation process is that the safety risk of halogenated reagents is unignorable. The traditional nitration process is mostly carried out in a strong acidic environment and yet recently the non-acid system and photocatalytic nitration are proposed in line with the green chemistry standards. In view of the toxicological data in the existing literature, it is found that the toxicities of the precursors in hydrolysis process are significantly higher than those in the halogenation and nitration processes. Through all-round comprehensive evaluation, it can be concluded that adopting a nitrification process may minimize the pressure of chemical enterprises in terms of cost, energy consumption, environmental protection and safety.
In this study, the synthetic method of the small molecule antineoplastics alpelisib(BYL719, 1) was improved. Using 2,4-dibromopyridine as the starting material, the key intermediate 4-bromo-2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridine(8) was obtained via 5 steps, including nucleophilic substitution, silylation protection, deprotection, methanesulfonylation and substitution. Intermediate 8 condensed with [2-[(tert-butoxycarbonyl)amino]-4-methylthiazol-5-yl]boronic acid under the Pd-catalyzed Suzuki coupling reaction to give [4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-tert-butyl thiazol-2-yl]carbamate. Followed by removing the Boc protection group and condensation, the target compound 1 was obtained in a 15.9% total yield.
To improve the quality of sodium valproate, a commonly used anti-epileptic drug, its related substance 2-isopropyl pentanoic acid(1) was synthesized. The compound methyl 2-cyano-valerate(3) was obtained by the reaction of methyl cyanoacetate(2) and bromopropane in methanol solution of sodium methoxide. And then, 3 was reacted with 2-iodopropane in methanol solution of sodium methoxide to synthesize methyl 2-cyano-2-isopropyl valenate(5). Followed by hydrolysis and decarboxylation, hydrolysis with sodium hydroxide and acidification with sulfuric acid, the title compound 1 was obtained with a total yield of 4% and the purity of 98%.
Mesenchymal stem cells(MSCs) are distributed widely in the human body. MSCs have powerful self-renewal ability, pluripotency, and immunomodulation property. Due to the damaged tissue and tumor site tropism, MSCs that express antibodies have potential applications in tumor therapy. However, the low efficiency of MSC transfection restricts their application. This study optimized four transfection methods for human umbilical cord blood-derived MSCs. The results showed that with the optimal packaging conditions[m(DNA)∶m(Lipo)=1∶2, m(vector)∶m(psPAX2)∶m(VSVG)=3∶2∶1], lentivirus produced by three-plasmid system could infect MSCs more efficiently, 50% of MSCs could express target protein successfully. In addition, MSCs expressing two antibodies with different structures, Anti-CD24 and BiTE-Fc, were successfully constructed with the above methods, respectively, providing the research basis for applying MSCs in tumor therapy.
Acacetin(1) is a natural flavone that can prevent atrial fibrillation in vivo and in vitro with high specificity. However, low solubility and short half-life severely of 1 limit its medicinal application. In order to improve its water solubility and enhance oral absorption, two 1 glycosyl prodrugs targeting the intestinal sodium-glucose transporter1(SGLT1) were designed and synthesized. The results of Caco-2 cell transport experiment showed that the permeabilities of the two 1 glycosyl prodrugs were higher than 1. The permeability of the glycosyl prodrug was mediated by SGLT1 and was affected by the efflux of multi-drug resistant proteins. The pharmacokinetics results in rats showed that the cmax values of monosaccharide and disaccharide derivatives of 1 were 5 and 30 times higher than that of 1, respectively. The AUC values of them was 10 and 100 times higher than that of 1, respectively, and the half-lives of both derivatives were extended for about 2 hours. These results indicated that glycosyl modification of 1 could effectively enhance its oral absorption.
The optimal formulation of chlorogenic acid(1) liposomes was developed using a combination of Box-Behnken design and response surface methodology. Subsequently, the liposomes were surface modified with chitosan. The results of transmission electron microscopy revealed that liposomes with or without surface modification were spherical, while the surface modification liposomes displayed a distinct core-shell structure. The average particle sizes of above two liposomes were (185.0±10.8) and (265.0±11.9)nm, respectively, while the ζ potentials were (–18.3±2.1) and(45.6±3.5)mV. The results of in vitro release test indicated that the release behavior of 1 from the unmodified liposomes fit the Higuchi model well, while the chitosan-modified liposomes exhibited a better fit to the Korsmeyer-Peppas model. The improved Franz diffusion cell method was used to investigate the in vitro transdermal performance of the product on mouse skin. The steady-state permeation fluxes of 1 solution, 1 liposomes and chitosan-modified 1 liposomes were 1.77, 0.98 and 0.73 μg·cm–2·h–1, respectively, with skin retention at 36 h of (113.4±7.4), (399.6±5.5), and (519.6±13.1)μg/cm2. These results suggested that chitosan-modified 1 liposomes had lower skin penetration but higher skin retention than those of 1 solution and 1 liposomes, making them a promising candidate for transdermal drug delivery.
Hyaluronic acid(HA) and glycyrrhetinic acid(GA) were chemically bonded to prepare the HA-GA composite with CD44 receptor targeting property, then the polymeric micelles of HA-GA composite were obtained. The pharmaceutical properties and anti-hepatic fibrosis activity in vitro were evaluated by MTT assay and enzyme linked immunosorbent assay. The results showed that the critical micelle concentration of the HA-GA composite was 9.6 μg/mL, the particle size of the polymeric micelles was 217.0 nm, and the GA content was 18.9%. Compared with the GA solution, HA-GA polymeric micelles showed potent cytotoxicity, meanwhile could inhibit the secretion of transforming growth factor β1 by hepatic stellate cells, exhibiting well anti-hepatic fibrosis activity in vitro.
A gel solution was prepared by heating the mixture of gelatin, partially dehydrated sorbitol, glycerin and water. An opacifier and other ingredients were added into above solution to obtain the gelatin film shell. A Box-Behnken design-response surface method was employed to optimize the gelatin film shell with material mobility, equilibrium swelling amount, water vapor permeability, light transmittance, and disintegration time as the dependent variables, and with gelatin grade, the mass ratio of partially dehydrated sorbitol to glycerin, and the proportion of titanium dioxide as the independent variables. The optimal gelatin film shell formulation was as follows: the gelatin strength was 150 g bloom, the mass ratio of partially dehydrated sorbitol to glycerin was 2.3∶10, and the proportion of titanium dioxide to gelatin was 1.18%. Three consecutive batches of gelatin film shell were manufactured based on the optimized formulation. The deviations of actual material mobility values, equilibrium swelling amount, and light transmittance from the predicted values were no more than 1.7%. The inter-batch RSD did not exceed 0.36%. These results indicated that the optimized gelatin film shell formulation had good accurate, reproducible and stability. This study could provide some references to improve the industrialized production of soft capsules.
An UPLC-MS/MS method was established to determine the cycloastragenol(1) in plasma of SD rats and Beagle dogs. 20(S)-Protopanaxadiol was used as an internal standard and methanol was used to precipitate the protein. In addition, the in vivo tests were designed to investigate the pharmacokinetic behavior of 1 in SD rats and Beagle dogs after oral administration or injection of 1. Twenty-four SD rats were randomly divided into four groups, 1 suspension with doses of 1, 3 and 10 mg/kg was given by gavage, and 1 injection with a dose of 1 mg/kg was given intravenously. The results showed that the tmax of 1 suspension of 1, 3 and 10 mg/kg orally administered to SD rats was 0.5 h, the t1/2 was 0.82 - 0.93 h, and the AUC0→t were 190, 602, 1 818 μg·L- 1·h, respectively. The plasma exposure increased linearly with the dosage, and the oral bioavailability was 29.4%. Twelve Beagle dogs were randomly divided into two groups, 1 suspension with a dose of 30 mg/kg was given by gavage and 1 injection with a dose of 1 mg/kg was given intravenously. The results showed that the tmax of 1 suspension was 0.5 h, the t1/2 was 1.26 h, and the AUC0→t was 110 μg·L–1·h. The elimination rate was slightly slower than that of SD rats and the oral bioavailability was 0.5%. This study reported the comparison of the pharmacokinetics of 1 suspension in SD rats and Beagle dogs, which provided a reference for the further study of this drug.
An HPLC-CAD method was established for the determination of seven related substances(2 - 8) in sugammadex sodium(1) bulk drug. The Poroshell 120 SB-C8 column(4.6 mm×150 mm, 2.7 μm) was used, and the analysis was carried out in the linear gradient elution mode with 0.5% formic acid solution as mobile phase A, and methanol as mobile phase B. The flow rate was 0.5 mL/min and the column temperature was 35 ℃. The temperature of the atomizer of the charged aerosol detector(CAD) was 35 ℃, the filtration constant was 3.6 s, and the data acquisition rate was 5 Hz. The results showed that it was linear for 3 in the range of 5 - 300 μg/mL, and it was linear for 1 bulk drug and other related substances in the range of 2 - 40 μg/mL. The LOQs and LODs of 1 - 8 were 0.985 - 1.145 μg/mL and 0.493 - 0.573 μg/mL, respectively. The average recoveries(n=9) of 2 - 8 were 95.6% - 99.4%, with the RSDs of 1.21% -3.32%. This method is accurate, reproducible, and highly precise, which can be used to detect the related substances in 1 bulk drug, and also provides a reliable detection method for the quality control of 1.